National HealthCare vs Sonida Senior Living
NHC and SNDA side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How NHC and SNDA compare
National HealthCare is the larger company, worth 2.0 times as much as Sonida Senior Living ($3.2B against $1.6B).
Sonida Senior Living grew revenue faster over the last twelve months (49.4% versus 6.9% for National HealthCare).
National HealthCare keeps more of each dollar of sales as profit, with a net margin of 9.0% compared with −23.3% at Sonida Senior Living.
National HealthCare pays a dividend yielding 1.3%; Sonida Senior Living does not pay one.
National HealthCare scores higher on the StockData Score (21 against 4 for Sonida Senior Living), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | NHC | SNDA |
|---|---|---|
| Size and price | ||
| Market cap | $3.2B | $1.6B |
| Share price | $206.14 | $34.30 |
| Change, 1 year | 70.6% | 33.3% |
| Change, 5 years | 170% | 21.2% |
| Beta (5Y) | 0.44 | 0.60 |
| Employees | 15K | 5,140 |
| StockData Score | ||
| Total score | 21 (better) | 4 |
| Valuation score | 2 | 2 |
| Growth score | 4 (better) | 2 |
| Performance score | 5 (better) | 0 |
| Health score | 6 (better) | 0 |
| Dividend score | 4 (better) | 0 |
| Valuation | ||
| P/E | 23.2× | – |
| P/S | 2.1× (better) | 3.1× |
| P/B | 2.9× | 1.9× (better) |
| EV/EBITDA | 16.8× (better) | 128× |
| P/FCF | 22.0× | – |
| PEG | 0.31 | – |
| FCF yield | 4.5% (better) | −3.2% |
| Fair value | $170.67 | $37.39 |
| Margin of safety | −20.8% | 8.3% (better) |
| Growth | ||
| Revenue growth (TTM) | 6.9% | 49.4% (better) |
| Revenue growth, 5Y average | 8.1% (better) | −0.14% |
| Net income growth (TTM) | 33.8% | – |
| EPS growth (TTM) | 32.5% | – |
| EPS growth, 5Y average | 23.0% | – |
| Profitability | ||
| Operating margin | 9.3% | – |
| Net margin | 9.0% (better) | −23.3% |
| FCF margin | 9.4% (better) | −10.0% |
| Return on equity | 13.1% (better) | −26.7% |
| Return on invested capital | 10.6% | – |
| Financial health | ||
| Debt / equity | 0.00 | 1.82 (better) |
| Net debt / EBITDA | −0.21 | 61.23 (better) |
| Interest coverage | 56.6× | – |
| Current ratio | 1.86 (better) | 0.88 |
| Altman Z-score | 7.03 (better) | 0.48 |
| Piotroski F-score | 6 (better) | 2 |
| Dividends and buybacks | ||
| Dividend yield | 1.3% | – |
| Payout ratio | 28.4% | – |
| Years of dividend growth | 12 | – |
| Dividend growth, 5Y average | 4.0% | – |
| Buyback yield | 0.15% (better) | −6.6% |
| Shareholder yield | 1.4% (better) | −6.6% |
| Ownership | ||
| Held by institutions | 65.3% | 78.4% |
| Held by insiders | 9.3% | 64.4% |
| Insider net buying, 12 months | −$11.0M | $89.0M (better) |
| Short interest, % of float | 5.8% | 20.6% |
Go deeper
- NHC stock overview
- NHC income statement
- NHC valuation and score
- SNDA stock overview
- SNDA income statement
- SNDA valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.